A topic in the Open Knowledge Graph — a free, open map of 15,290 topics and the order to learn them in.
Lipoproteins are spherical particles with a hydrophobic lipid core and hydrophilic apolipoprotein shell, enabling lipid transport in blood. VLDL and chylomicrons deliver triglycerides; LDL delivers cholesterol. HDL removes excess cholesterol via reverse cholesterol transport. Apolipoprotein composition determines lipoprotein class and metabolic fate.
From your study of cholesterol metabolism, you know that lipids — fats, cholesterol, and fat-soluble vitamins — are hydrophobic molecules that cannot dissolve in the aqueous environment of blood plasma. This creates a fundamental transport problem: how does the body move lipids from where they are absorbed or synthesized to where they are needed? The solution is lipoproteins, spherical shuttle particles that package hydrophobic cargo inside a water-compatible shell.
The architecture of a lipoprotein is elegantly simple. The core contains the hydrophobic cargo — triglycerides and cholesterol esters — shielded from water. The surface is a monolayer of phospholipids (with their hydrophilic heads facing outward), interspersed with free cholesterol and specialized proteins called apolipoproteins. Think of it like a delivery truck: the cargo bay (core) carries the goods, the exterior (phospholipid shell) interfaces with the road (blood), and the license plates and GPS (apolipoproteins) determine where the truck goes and who can unload it. Apolipoproteins serve as receptor ligands, enzyme activators, and structural scaffolds — they are what gives each lipoprotein class its identity and metabolic fate.
The major lipoprotein classes form a transport system with distinct roles. Chylomicrons, assembled in the intestinal epithelium, carry dietary triglycerides from the gut to peripheral tissues. VLDL (very-low-density lipoprotein), made in the liver, carries endogenously synthesized triglycerides outward. As VLDL delivers its triglyceride cargo (via lipoprotein lipase on capillary walls), it shrinks and becomes denser, transitioning through IDL to LDL (low-density lipoprotein), which is now cholesterol-rich and delivers cholesterol to cells via the LDL receptor. Finally, HDL (high-density lipoprotein) performs reverse cholesterol transport — it scavenges excess cholesterol from peripheral tissues and returns it to the liver for excretion in bile. The density naming reflects lipid-to-protein ratio: more lipid means less dense (chylomicrons float), more protein means more dense (HDL sinks).
This system explains the clinical shorthand of "good" and "bad" cholesterol. Elevated LDL means more cholesterol is being delivered to artery walls, where it can accumulate and drive atherosclerosis. Elevated HDL means more cholesterol is being removed from tissues and returned to the liver. But the particles themselves are not inherently good or bad — they are components of a regulated transport system. When regulation fails (receptor deficiency as in familial hypercholesterolemia, or overproduction of VLDL from excess hepatic lipogenesis), the balance tips toward accumulation, and cardiovascular risk rises. Understanding lipoprotein biology transforms cholesterol from a single lab number into a dynamic story of packaging, delivery, and clearance.